For more trusted health
news and information,
visit CBS Boston's
BOSTON (CBS) – Multiple sclerosis is a devastating disease, but a pharmaceutical based here in Massachusetts is developing a drug that they hope will ease suffering for a lot of MS patients.
Biogen Idec has just announced that this drug is a step closer to being approved. How will the news impact the company’s stock?
Lisa van der Pool of the Boston Business Journal reports: